|
TTC14 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.393040E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.087200E-01 |
| Normal-vs-Stage2 |
3.352400E-01 |
| Normal-vs-Stage3 |
1.047780E-01 |
| Normal-vs-Stage4 |
9.468600E-01 |
| Stage1-vs-Stage2 |
5.711000E-01 |
| Stage1-vs-Stage3 |
3.542800E-03 |
| Stage1-vs-Stage4 |
6.668000E-01 |
| Stage2-vs-Stage3 |
9.013900E-02 |
| Stage2-vs-Stage4 |
5.190400E-01 |
| Stage3-vs-Stage4 |
2.554800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.243820E-01 |
| Normal-vs-AfricanAmerican |
3.562400E-01 |
| Normal-vs-Asian |
7.368400E-01 |
| Caucasian-vs-AfricanAmerican |
7.438800E-01 |
| Caucasian-vs-Asian |
9.282000E-01 |
| AfricanAmerican-vs-Asian |
9.813000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.135800E-01 |
| Normal-vs-Female |
1.201810E-01 |
| Male-vs-Female |
4.521000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.550600E-01 |
| Normal-vs-Extreme_Weight |
5.890000E-01 |
| Normal-vs-Obese |
1.995570E-01 |
| Normal-vs-Extreme_Obese |
1.414440E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.688200E-01 |
| Normal_Weight-vs-Obese |
3.628200E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.591400E-01 |
| Extreme_Weight-vs-Obese |
3.620000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.053000E-01 |
| Obese-vs-Extreme_Obese |
6.705600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.428800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.923900E-02 |
| Normal-vs-Age(61-80Yrs) |
3.912800E-01 |
| Normal-vs-Age(81-100Yrs) |
2.611400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.266400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.507200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.029770E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.263800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.282100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.859970E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.882100E-03 |
| Normal-VS-Type2 PRCC |
1.395860E-02 |
| Normal-VS-KIRP CIMP |
7.022800E-01 |
| Normal-VS-Unclassified PRCC |
2.001000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.03269631629632E-11 |
| Type1 PRCC-VS-KIRP CIMP |
6.340200E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
5.059400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.123600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.041100E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
1.163830E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.067000E-01 |
| Normal-vs-N1 |
4.290400E-01 |
| Normal-vs-N2 |
1.082570E-01 |
| N0-vs-N1 |
3.379000E-01 |
| N0-vs-N2 |
1.886950E-01 |
| N1-vs-N2 |
1.560780E-01 |
|
|
